Exelixis (EXEL) News Today $42.39 -0.47 (-1.10%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$42.62 +0.23 (+0.55%) As of 05/23/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why is Exelixis Down Today?Exelixis, Inc. (NASDAQ: EXEL) shares are trading higher as investors weigh a string of bullish analyst actions, encouraging clinical data and significant institutional inflows—partially offset by insider sales. Zacks upgraded EXEL to a #2 (Buy) rank, signaling rising confidence in the company’s upcoming earnings. Analyst revisions lifted earnings estimates for EXEL, underlining stronger near-term revenue prospects. William Blair maintained its Buy rating, citing zanzalintinib’s demonstrated efficacy and anticipated Phase III trial success. Phase 1b/2 STELLAR-002 expansion cohort data showed superior efficacy of the zanzalintinib/Opdivo combo in advanced kidney cancer. “Big Money” inflows suggest heavy institutional buying interest in Exelixis shares. A growth-oriented analysis highlighted three reasons why Exelixis could outperform its biotech peers. A comparative report evaluated Exelixis vs. argenex (ARGX) to determine the better value opportunity in biotech. Management will host fireside chats at the TD Cowen Oncology Innovation Summit and the William Blair Growth Stock Conference in late May and June. Director Tomas J. Heyman sold 4,544 shares—reducing his stake by 12.3% at an average price of $44.29. EVP Patrick J. Haley sold 34,387 shares (about $1.5 million) at roughly $44.06 per share. Positive catalysts are driving EXEL higher, though recent insider selling indicates some executives are taking profits at current levels.Posted 1+ days agoAI Generated. May Contain Errors. EXEL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Voloridge Investment Management LLC Makes New Investment in Exelixis, Inc. (NASDAQ:EXEL)Voloridge Investment Management LLC acquired a new position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 910,534 shares of the biotechnology company's stock, valued at approximatelyMay 24 at 5:22 AM | marketbeat.comTidal Investments LLC Grows Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL)Tidal Investments LLC increased its position in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 187.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 104,665 shares of the biotechnology coMay 24 at 4:45 AM | marketbeat.comExelixis Announces Encouraging Results from Phase 1b/2 STELLAR-002 Trial Evaluating Zanzalintinib in Combination with Immune Checkpoint Inhibitors in Advanced Kidney Cancer at ...May 23 at 6:48 PM | morningstar.comExelixis, Inc. (NASDAQ:EXEL) Director Tomas J. Heyman Sells 4,544 SharesMay 23 at 8:05 AM | insidertrades.comTwo Sigma Investments LP Buys 478,889 Shares of Exelixis, Inc. (NASDAQ:EXEL)Two Sigma Investments LP boosted its stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 56.4% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,328,553 shares of the biotechnology company's stock after acquiring an additionalMay 23 at 5:37 AM | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Shares Bought by State of WyomingState of Wyoming increased its holdings in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 357.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 12,360 shares of the biotechnology company's stock after buying an additional 9,658 shares during the period. StatMay 23 at 5:16 AM | marketbeat.comPromising Outlook for Exelixis: Buy Rating Backed by Zanzalintinib’s Efficacy and Anticipated Phase III Trial SuccessMay 23 at 4:17 AM | tipranks.comExelixis EVP Haley Patrick J. sells $1.5 million in stockMay 22 at 7:46 PM | investing.comExelixis Announces Encouraging Results from Phase 1b/2 STELLAR-002 Trial Evaluating Zanzalintinib in Combination with Immune Checkpoint Inhibitors in Advanced Kidney Cancer at ASCO 2025May 22 at 5:17 PM | businesswire.comExelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in May and JuneMay 22 at 4:05 PM | businesswire.comVident Advisory LLC Acquires 36,850 Shares of Exelixis, Inc. (NASDAQ:EXEL)Vident Advisory LLC boosted its holdings in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 31.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 155,874 shares of the biotechnology company's stock after acquiriMay 22 at 5:59 AM | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Shares Sold by Two Sigma Advisers LPTwo Sigma Advisers LP decreased its stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 4.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,627,890 shares of the biotechnology company's stock after selling 74,700 shares during the periodMay 22 at 5:26 AM | marketbeat.comMan Group plc Lowers Position in Exelixis, Inc. (NASDAQ:EXEL)Man Group plc cut its stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 19.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 238,506 shares of the biotechnology company's stock after selling 59,204 shares during theMay 22 at 4:34 AM | marketbeat.comTeza Capital Management LLC Buys Shares of 31,021 Exelixis, Inc. (NASDAQ:EXEL)Teza Capital Management LLC bought a new stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 31,021 shares of the biotechnology company's stock, valued at approximately $1,033,000. AMay 21, 2025 | marketbeat.com49,256 Shares in Exelixis, Inc. (NASDAQ:EXEL) Bought by Tema Etfs LLCTema Etfs LLC acquired a new position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 49,256 shares of the biotechnology company's stock, valued at approximately $1,640,000. A nMay 20, 2025 | marketbeat.comRafferty Asset Management LLC Has $7.27 Million Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL)Rafferty Asset Management LLC decreased its stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 4.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 218,357 shares of the biotechnology company's stock after seMay 20, 2025 | marketbeat.comLaird Norton Wetherby Wealth Management LLC Takes $234,000 Position in Exelixis, Inc. (NASDAQ:EXEL)Laird Norton Wetherby Wealth Management LLC bought a new stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 7,015 shares of the biotechnology company's stockMay 20, 2025 | marketbeat.comRedwood Investment Management LLC Makes New $1.41 Million Investment in Exelixis, Inc. (NASDAQ:EXEL)Redwood Investment Management LLC bought a new position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 42,286 shares of the biotechnology company's stock, valued at approximatelMay 19, 2025 | marketbeat.comNomura Holdings Inc. Lowers Stake in Exelixis, Inc. (NASDAQ:EXEL)Nomura Holdings Inc. lowered its position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 35.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 64,601 shares of the biotechnology company'May 19, 2025 | marketbeat.comNuveen Asset Management LLC Sells 221,143 Shares of Exelixis, Inc. (NASDAQ:EXEL)Nuveen Asset Management LLC cut its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 5.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,499,915 shares of the biotechnMay 19, 2025 | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Shares Acquired by Bank of America Corp DEBank of America Corp DE raised its stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 7.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,214,689 shares of the biotechnology company's stock aMay 18, 2025 | marketbeat.comExelixis (NASDAQ:EXEL) Cut to "Buy" at StockNews.comMay 18, 2025 | americanbankingnews.comInsider Selling: Exelixis, Inc. (NASDAQ:EXEL) EVP Sells 10,000 Shares of StockMay 17, 2025 | insidertrades.comRedwood Investments LLC Takes Position in Exelixis, Inc. (NASDAQ:EXEL)Redwood Investments LLC purchased a new position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 122,921 shares of the biotechnology company's stock, valuedMay 17, 2025 | marketbeat.comLazard Asset Management LLC Increases Stock Position in Exelixis, Inc. (NASDAQ:EXEL)Lazard Asset Management LLC lifted its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 80.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 214,462 shares of the biotechnology compMay 17, 2025 | marketbeat.comGraham Capital Management L.P. Boosts Stake in Exelixis, Inc. (NASDAQ:EXEL)Graham Capital Management L.P. lifted its stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 81.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,821 shares of the biotechnology company's stock afteMay 17, 2025 | marketbeat.comRoyal Bank of Canada Reiterates "Outperform" Rating for Exelixis (NASDAQ:EXEL)May 17, 2025 | americanbankingnews.comPrice Over Earnings Overview: ExelixisMay 16, 2025 | benzinga.comThese Stocks Are Moving the Most Today: Nvidia, AMD, Super Micro, UnitedHealth, eToro, Oklo, Exelixis, and MoreMay 16, 2025 | msn.comExelixis, Inc. (NASDAQ:EXEL) Shares Sold by Ameriprise Financial Inc.Ameriprise Financial Inc. cut its stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 41.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 933,675 shares of the biotechnology company's stock after selling 657May 16, 2025 | marketbeat.comHot or Not, Stock Market Edition: 05/16/2025May 16, 2025 | wallstreetzen.comExelixis (NASDAQ:EXEL) Stock Price Up 5.7% Following Analyst UpgradeMay 16, 2025 | americanbankingnews.comInvestors Purchase High Volume of Exelixis Call Options (NASDAQ:EXEL)May 16, 2025 | americanbankingnews.comDemystifying Exelixis: Insights From 8 Analyst ReviewsMay 15, 2025 | benzinga.comMubadala Investment Co PJSC Makes New $2.32 Million Investment in Exelixis, Inc. (NASDAQ:EXEL)Mubadala Investment Co PJSC bought a new position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 69,579 shares of the biotechnology company's stock, valuedMay 15, 2025 | marketbeat.comHudson Bay Capital Management LP Invests $4.16 Million in Exelixis, Inc. (NASDAQ:EXEL)Hudson Bay Capital Management LP bought a new stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 125,000 shares of the biotechnologyMay 15, 2025 | marketbeat.comEnsign Peak Advisors Inc Lowers Holdings in Exelixis, Inc. (NASDAQ:EXEL)Ensign Peak Advisors Inc trimmed its holdings in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 10.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 335,000 shares of the biotechnology company's stMay 15, 2025 | marketbeat.comCaptrust Financial Advisors Acquires 20,027 Shares of Exelixis, Inc. (NASDAQ:EXEL)Captrust Financial Advisors increased its holdings in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 56.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 55,457 shares of the biotechnology company's stock aMay 15, 2025 | marketbeat.comExelixis Catapults To Record High After Obliterating First-Quarter ExpectationsMay 15, 2025 | investors.comExelixis, Inc. (NASDAQ:EXEL) Receives Average Rating of "Hold" from BrokeragesMay 15, 2025 | americanbankingnews.comExelixis Stock Soars As Analysts Applaud Raised 2025 Guidance, Q1 Earnings BeatMay 14, 2025 | benzinga.comExelixis: A Notable QuarterMay 14, 2025 | seekingalpha.comExelixis: A Notable QuarterMay 14, 2025 | seekingalpha.comThese Stocks Are Moving the Most Today: Nvidia, AMD, Super Micro, UnitedHealth, Oklo, Exelixis, Grail, and MoreMay 14, 2025 | msn.comWhy Exelixis Stock Is Skyrocketing TodayMay 14, 2025 | fool.comWhy Exelixis (EXEL) Shares Are Surging TodayMay 14, 2025 | gurufocus.comExelixis (EXEL) Maintains Outperform Rating with $40 Price Target | EXEL Stock NewsMay 14, 2025 | gurufocus.comExelixis Crushes Q1 Earnings Estimates With Strong Cabometyx Sales, Raises 2025 Revenue GuidanceMay 14, 2025 | benzinga.comThese Stocks Are Moving the Most Today: Nvidia, AMD, Super Micro, UnitedHealth, American Eagle, Exelixis, Grail, and MoreMay 14, 2025 | msn.comExelixis (EXEL) Receives Price Target Boost to $46 | EXEL Stock NewsMay 14, 2025 | gurufocus.com Get Exelixis News Delivered to You Automatically Sign up to receive the latest news and ratings for EXEL and its competitors with MarketBeat's FREE daily newsletter. Email Address EXEL Media Mentions By Week EXEL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EXEL News Sentiment▼1.060.75▲Average Medical News Sentiment EXEL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EXEL Articles This Week▼2414▲EXEL Articles Average Week Get Exelixis News Delivered to You Automatically Sign up to receive the latest news and ratings for EXEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alnylam Pharmaceuticals News Biogen News United Therapeutics News Incyte News Neurocrine Biosciences News BioMarin Pharmaceutical News Exact Sciences News Repligen News Halozyme Therapeutics News Madrigal Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EXEL) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exelixis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exelixis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EXEL Stock Free EXEL Stock Alerts